EP0565708A4 - Impfstoff gegen mukosapathogene unter verwendung von liposomen. - Google Patents

Impfstoff gegen mukosapathogene unter verwendung von liposomen.

Info

Publication number
EP0565708A4
EP0565708A4 EP19920924345 EP92924345A EP0565708A4 EP 0565708 A4 EP0565708 A4 EP 0565708A4 EP 19920924345 EP19920924345 EP 19920924345 EP 92924345 A EP92924345 A EP 92924345A EP 0565708 A4 EP0565708 A4 EP 0565708A4
Authority
EP
European Patent Office
Prior art keywords
mucosus
vaccines
pathogens
liposomes
used against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920924345
Other languages
English (en)
French (fr)
Other versions
EP0565708A1 (de
Inventor
Himanshu Brahmbhatt
Juergen Wehland
Robert M Brownlie
Kenneth Timmis
David C White
Carlos A Guzman
Mark J Walker
Michael W Fountain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Centre for Infection Research
Original Assignee
Helmholtz Centre for Infection Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Centre for Infection Research filed Critical Helmholtz Centre for Infection Research
Publication of EP0565708A1 publication Critical patent/EP0565708A1/de
Publication of EP0565708A4 publication Critical patent/EP0565708A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
EP19920924345 1991-11-06 1992-11-05 Impfstoff gegen mukosapathogene unter verwendung von liposomen. Withdrawn EP0565708A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4136553A DE4136553A1 (de) 1991-11-06 1991-11-06 Impfstoff gegen schleimhauterreger und herstellungsverfahren
DE4136553 1991-11-06

Publications (2)

Publication Number Publication Date
EP0565708A1 EP0565708A1 (de) 1993-10-20
EP0565708A4 true EP0565708A4 (de) 1994-03-15

Family

ID=6444214

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920924345 Withdrawn EP0565708A4 (de) 1991-11-06 1992-11-05 Impfstoff gegen mukosapathogene unter verwendung von liposomen.

Country Status (4)

Country Link
EP (1) EP0565708A4 (de)
JP (1) JPH06507420A (de)
DE (1) DE4136553A1 (de)
WO (1) WO1993008834A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677826B2 (en) * 1993-02-26 1997-05-08 Fountain Pharmaceuticals, Inc. Vaccine delivery system and shelf-stable precursor solution for remote encapsulation of active ingredients
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
AUPO301796A0 (en) 1996-10-16 1996-11-07 Resmed Limited A vent valve apparatus
DE19703437A1 (de) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
EP1031347B1 (de) * 1999-01-27 2002-04-17 Idea Ag Transnasaler Transport bzw. Impfung mit hochadaptierbaren Trägern
WO2007132790A1 (ja) * 2006-05-12 2007-11-22 National University Corporation Hokkaido University 細菌菌体成分を含む脂質膜を有するリポソーム

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7532327B2 (en) * 2004-09-17 2009-05-12 Jmar Research, Inc. Systems and methods for detecting scattered light from a particle using illumination incident at an angle

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
CA1340241C (en) * 1988-06-08 1998-12-15 Fountain Pharmaceuticals, Inc. Method for marking solvent dilution microcarriers
WO1990001947A1 (en) * 1988-08-25 1990-03-08 The Liposome Company, Inc. Affinity associated vaccine
NZ230424A (en) * 1988-08-25 1992-05-26 Liposome Co Inc Liposomal composition comprising an externally disposed antigen
NL9000207A (de) * 1990-01-29 1991-08-16 Duphar Int Res

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7532327B2 (en) * 2004-09-17 2009-05-12 Jmar Research, Inc. Systems and methods for detecting scattered light from a particle using illumination incident at an angle

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9308834A1 *

Also Published As

Publication number Publication date
WO1993008834A1 (en) 1993-05-13
DE4136553A1 (de) 1993-05-13
JPH06507420A (ja) 1994-08-25
EP0565708A1 (de) 1993-10-20

Similar Documents

Publication Publication Date Title
CY2007015I1 (el) Εμβολιο ιου θηλωματος
ID20399A (id) Vaksin influensa
FI935093L (fi) Hypodermiska naolar
DE69126606D1 (de) Vakzine
DK0671948T3 (da) Vaccinepræparat indeholdende adjuvanser
FI922613L (fi) Blandningar av kedjeformiga och cykliska siloxaner eller siloxanoligomerer, foerfarande foer deras framstaellning och deras anvaendning
FI923143L (fi) Homogeniska, stabila och flytande vattenblandningar och anvaendning av naemnda blandningar foer framstaellning av dispersioner av i vatten oloesliga substanser
FI923947A7 (fi) Foerfarande foer pulsbreddsmodulation foer oekad linearitet, minskad kommutationsfoerlust och oekad utspaenning i en vaexelriktare/omriktare
EP0662092A4 (de) Aktivitätsabhängiger neurotropher faktor.
FI920732L (fi) 2-substituerade kinoliner, foerfarande foer framstaellning av dessa och anvaendning av dessa i laekemedel
FI924869L (fi) Kinolinderivat, foerfarande foer framstaellning av dessa och terapeutisk anvaendning av dessa
DE3882781D1 (de) Impfstoff gegen pasteurella.
DE69115295D1 (de) Bausanierungsverfahren.
DE59204584D1 (de) Markise.
DE69021761D1 (de) Impfstoff gegen Tinea.
FI930702A7 (fi) Anordning foer omlastning av styckegods i form av lastningsenheter, saosom kontainers, vaexelbehaollare, paohaengsvagnar eller dylika
EP0967993A4 (de) Anti-kokaine vakzine
FI924279L (fi) I vaoningar anordnade, foer hissar avsedda anordningar foer anropsregistrering och display
ATA141891A (de) Saugwalze
DK0564620T3 (da) Vaccine mod dermatomycosis
DE69231883D1 (de) 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten
DE69206522D1 (de) Vibrator.
DE69020848D1 (de) Impfstoff gegen IBV.
FI924637L (fi) Foerfarande foer framstaellning av katalysatorer foer polymerisering av olefiner, katalysatorer erhaollna medelst detta foerfarande och foerfarandefoer polymerisering av olefiner i naervaro av dessa katalysatorer
EP0584212A4 (de) Liposomale polysaccharidimpfstoffe.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930803

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE

RHK1 Main classification (correction)

Ipc: A61K 39/10

17Q First examination report despatched

Effective date: 19970901

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990527